Bot Detector
IJPC Seal
Download FREE Sample Issue or Article
LEARN MORE
Subscribe Today
A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of your subscribed issues, individual articles, and purchased archives.

Update on Transdermals for Animal Patients

Author(s):  Davidson Gigi S

Issue:  May/Jun 2005 - Veterinary Compounding
View All Articles in Issue

Page(s):  178-182

Update on Transdermals for Animal Patients Page 1
Update on Transdermals for Animal Patients Page 2
Update on Transdermals for Animal Patients Page 3
Update on Transdermals for Animal Patients Page 4
Update on Transdermals for Animal Patients Page 5

Download in electronic PDF format for $75

Abstract:  Much insight has been gained into the disposition of transdermally administered medications to animal patients over the last 2 years. Scientific investigations are beginning to unravel the mystery of percutaneous drug disposition of transdermally applied drugs. While exact disease-specific protocols for transdermal drug therapy are yet to be determined, pulsed transdermal drug delivery in feline patients still offers much hope for life-saving, noninvasive therapeutic intervention. While the regulatory and scientific environments are still developing on the subject of pulsed transdermal therapy, this dosage form still represents one of the most promising therapeutic tools in the veterinarian’s “black bag.” By keeping pace with the results of scientific investigations in veterinary transdermal therapy and by practicing due diligence in chronicling transdermal therapeutic outcomes, the compounding pharmacist can maximally contribute to the veterinary care quadrad.

Related Keywords: transdermal preparation, percutaneous drug delivery, veterinary care

Related Categories: VETERINARY, FREE SAMPLES, DOSAGE FORMS/DRUG CARRIERS

Printer-Friendly Version



Related Articles from IJPC
Title/Author
(Click for Abstract / Details / Purchase)
Issue/​Page
View/Buy
Veterinary Transdermal Medications: A to Z
Davidson Gigi S
Mar/Apr 2003
Pg. 106-113

Update on Transdermals for Animal Patients
Davidson Gigi S
May/Jun 2005
Pg. 178-182

View Sample
Preparation and In Vitro Evaluation of a Pluronic Lecithin Organogel Containing Ricinoleic Acid for Transdermal Delivery
Boddu Sai HS
, Bonam Sindhu Prabha, Wei Yangjie, Alexander Kenneth
May/Jun 2014
Pg. 256-261

The Use of Pluronic Lecithin Organogels in the Transdermal Delivery of Drugs
Bramwell Bethany L
, Williams LaVonn A
Jan/Feb 2012
Pg. 62-63

Transdermals: The Skin as Part of a Drug Delivery System
Allen Loyd V Jr
Jul/Aug 2011
Pg. 308-315

Evaluating Transdermal Medication Forms for Veterinary Patients, Part 3: Methimazole
Davidson Gigi S
Jul/Aug 2001
Pg. 282-283

Transdermal Delivery of Nisoldipine: Refinement of Vehicles
El Maghraby Gamal M
, Ahmed Amal A, Osman Mohamed A
Mar/Apr 2015
Pg. 152-160

Transdermal Delivery of Metformin Hydrochloride from a Semisolid Vehicle
Polonini Hudson
, Lopes Cândido Paulo José, Andrade Junquiera Laura, Loures Sharlene, Raposo Nádia RB, Fernandes Brandão Marcos Antônio, de Oliveira Ferreira Anderson
Jan/Feb 2019
Pg. 65-69

Effect of Penetration Enhancers on the Percutaneous Delivery of Pain Management Actives
Trimble John
, Light Bob
May/Jun 2016
Pg. 250-256

Compounding Transdermal Medication for Feline Patients
Eichstadt Lauren R
Jul/Aug 2016
Pg. 271-274

To Compound or Not to Compound: A Veterinary Transdermal Discussion
Eichstadt Lauren R
, Davidson Gigi S
Sep/Oct 2014
Pg. 366-369

Evaluation of Percutaneous Absorption Performance for Human Female Sexual Steroids into Pentravan Cream
Polonini Hudson C
, Brandão Marcos Antônio F, Ferreira Anderson O, Ramos Cristiano, Raposo Nádia R B
Jul/Aug 2014
Pg. 332-340

Feline Transdermal Formulation Considerations
Forsythe Lauren Eichstadt
Nov/Dec 2017
Pg. 446-452

Unlicensed Transdermal Medications in Feline Patients: Three Case Reports
Urwin Craig
, Jean Linda, Carvalho Maria, Robson-Laws Michael
Nov/Dec 2022
Pg. 468-472

Compatibility of Gestrinone, Nimesulide, and Piroxicam in Pentravan for Transdermal and Transmucosal Application
Polonini Hudson
, de Oliveira Ferreira Anderson, Dijkers Eli
Sep/Oct 2021
Pg. 422-426

Evaluation of Compounded Transdermal Analgesic Formulations Using the Franz Finite Dose Model
Baneshi Marzieh
, Tyagi Deependra, Panneerselvam Ezilrani, MacKenzie Graham, Coleman Johngary, Zhang Shine X
Sep/Oct 2023
Pg. 424-430

Evaluating Transdermal Medication Forms for Veterinary Patients, Part 1
Davidson Gigi S
Mar/Apr 2001
Pg. 95-96

Personalized Medicine and Customized Drug Delivery Systems: The New Trend of Drug Delivery and Disease Management
Soni Abhishek
, Gowthamarajan Kuppusamy, Radhakrishnan Arun
Mar/Apr 2018
Pg. 108-121

Percutaneous Absorption of Lorazepam, Diphenhydramine Hydrochloride, and Haloperidol from ABH Gel
Dahal Amit
, Neupane Rabin, Boddu Sai HS, Renukuntla Jwala, Khupse Rahul, Dudley Richard
Mar/Apr 2020
Pg. 168-175

When to Compound Medications for Veterinary Patients
Forsythe Lauren Eichstadt
Jan/Feb 2017
Pg. 19-21

Return to Top